Information about Leukeran (Chlorambucil)
Leukeran is a chemotherapy medication that contains chlorambucil, an alkylating agent. It is primarily used in the treatment of certain types of cancer, particularly hematological malignancies, such as chronic lymphocytic leukemia (CLL) and lymphoma.
Product Highlights
- Treatment of chronic lymphocytic leukemia (CLL).
- Management of non-Hodgkin lymphoma.
- Used in certain cases of Hodgkin's lymphoma and other hematological malignancies.
Key Ingredient
Key Benefits
- Proven efficacy in controlling symptoms and progression of specific blood cancers.
- Convenient tablet formulation allows for at-home treatment.
- Dosing can be tailored based on patient response and tolerance.
Direction of Use
- Typically initiated at a dose of 0.1 to 0.2 mg/kg body weight per day, adjusted based on clinical response and side effects.
- Take orally with or without food; follow the prescribed schedule closely for optimal effectiveness.
Safety Concerns
- May include nausea, vomiting, diarrhea, and bone marrow suppression, leading to increased risk of infection or bleeding.
- Rarely associated with secondary malignancies, liver toxicity, and severe allergic reactions.
Avoid Leukeran (Chlorambucil) If
- You have a known allergy to chlorambucil or any other components of the formulation.
- You have severe bone marrow suppression or significant liver impairment.
- You are pregnant, planning to become pregnant, or breastfeeding without consulting a healthcare professional.
This product requires special packaging to maintain its integrity during the shipping process. DO NOT USE THIS MEDICATION if the attached temperature indicator shows that the medication was exposed to temperatures below 2 degrees or above 8 degrees Celsius, and contact the pharmacy immediately.
